Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

Merck and Co Inc

MRK
127,99
0,49 (0,38%)
19 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/6/202413:02IHMARKETNEWSFisker Files for Bankruptcy, Chegg Stocks Rise on 23%..
17/6/202423:29BWU.S. FDA Approves CAPVAXIVE™ (Pneumococcal 21-valent..
17/6/202423:15BWFDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus..
05/6/202412:45BWMerck to Participate in the Goldman Sachs 45th Annual Global..
04/6/202421:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202421:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202420:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202420:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202420:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202420:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202420:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202420:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202420:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202420:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202420:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202415:10IHMARKETNEWSEconomic Worries May Lead To Weakness On Wall Street
30/5/202422:39EDGAR2Form CERT - Certification by an exchange approving..
30/5/202422:28EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
30/5/202422:14EDGAR2Form 8-K - Current report
29/5/202415:10IHMARKETNEWSRising Treasury Yields May Weigh On Wall Street
29/5/202413:34IHMARKETNEWSRobinhood Shares Surge 3.3% on Stock Buyback Announcement;..
29/5/202413:15BWFDA Grants Priority Review to Merck’s Application for..
29/5/202412:45BWMerck to Acquire EyeBio
28/5/202422:44IHMARKETNEWSNasdaq Climbs To Another Record Closing High But Dow Sees..
28/5/202422:31EDGAR2Form SD - Specialized disclosure report
28/5/202421:12BWMerck Announces Third-Quarter 2024 Dividend
28/5/202412:45BWMerck Announces Phase 3 KEYNOTE-522 Trial Met its Overall..
20/5/202412:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
16/5/202422:15EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
15/5/202417:31EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
15/5/202412:45BWMerck to Present New Data at 2024 ASCO Annual Meeting..
13/5/202412:45BWMerck Provides Update on Phase 3 KeyVibe-010 Trial..
09/5/202413:05PRNCAHealth Canada Approves KEYTRUDA® for adult patients with..
09/5/202412:45BWMerck Provides Update on Phase 3 KEYNOTE-B21 Trial..
08/5/202412:45BWMerck to Participate in the Bank of America Securities 2024..
06/5/202422:29EDGAR2Form 144 - Report of proposed sale of securities
06/5/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/5/202413:15BWMerck Announces Phase 3 KEYNOTE-811 Trial Met Dual Primary..
29/4/202415:00BWMerck Announces Positive Data for V116, an Investigational,..
25/4/202422:40IHMARKETNEWSU.S. Stocks Climb Well Off Worst Levels But Close Mostly..
25/4/202415:09IHMARKETNEWSFutures Pointing To Sharply Lower Open On Wall Street
25/4/202413:52IHMARKETNEWSSouthwest Shares Tumble 9.6% Post $231 Million 1Q Loss,..
25/4/202412:30BWMerck Announces First-Quarter 2024 Financial Results
19/4/202413:04PRNCAHealth Canada Approves KEYTRUDA® as a first-line treatment..
10/4/202413:13IHMARKETNEWSDelta Generates US$37 Million Profit in Q1, Google and Intel..
04/4/202412:45BWMerck Initiates Phase 3 Clinical Trial of MK-1084, an..
03/4/202414:00BWREJOICE-Ovarian01 Phase 2/3 Trial of Raludotatug Deruxtecan..
Apertura: 128,67 Min: 127,0901 Max: 128,73
Chiusura: 127,50

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network